• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: EDWARDS LIFESCIENCES EDWARDS INSPIRIS RESILIA AORTIC VALVE; TISSUE, HEART-VALVE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

EDWARDS LIFESCIENCES EDWARDS INSPIRIS RESILIA AORTIC VALVE; TISSUE, HEART-VALVE Back to Search Results
Model Number 11500A
Device Problem Appropriate Term/Code Not Available (3191)
Patient Problem No Code Available (3191)
Event Date 06/17/2019
Event Type  Injury  
Manufacturer Narrative
Udi: (b)(4).The device was not returned to edwards for evaluation.Attempts to retrieve the device and additional information are in process.The device history record (dhr) was reviewed and shows that this device met all manufacturing specifications for product release prior to distribution.No issues were identified that would have impacted this event.Based on the information received the cause of the event cannot be determined.No further corrective or preventative actions are required at this time.Edwards lifesciences will continue to monitor all reported events.
 
Event Description
It was reported a patient initially implanted with a 21mm aortic valve for 3 months 28 days, had an explant procedure for unknown reasons.A 23mm surgical valve was implanted in the patient.The current patient status is unknown.
 
Event Description
It was reported that a patient implanted with a 21mm aortic valve for 3 months 28 days had an explant procedure due to endocarditis.The patient presented with new vegetation on the aortic and mitral valves.As the patient had symptoms of a recent embolic event, the patient was brought to the operative room for the high-risk surgical procedure.The entire aortic valve was resected with what appeared to be either abscess or destruction of the annulus into the level of the coronary ostia.The patient underwent total root replacement with a 23mm valve and 28mm valsalva graft.The native mitral valve was patched with bovine pericardial patch.Cabgx3 was performed.Intra-aortic balloon pump was placed.Eventually, the patient weaned off cardiopulmonary bypass with significant inotropic and vasopressor support.The patient expired in the operating room.
 
Manufacturer Narrative
Prosthetic endocarditis with or without vegetation, of valves and annuloplasty rings is a serious complication of valve replacement and valve repair surgeries despite improvements in prostheses types, surgical techniques, and infection control measures.This infection is generally categorized into early (onset usually less than 60 days postoperative) and late (onset greater than 60 days post-implantation).Late prosthetic endocarditis resembles native valve endocarditis in terms of etiological microbes, and sources of contamination are presumably similar.Late endocarditis occurs due to the implant being seeded from an infection or microbial contamination from elsewhere in the body.Dental, genitourinary, and gastrointestinal manipulation are known causes of transient bacteremia, which can place a patient at risk for prosthetic endocarditis.Additional procedures placing patients at risk for prosthetic endocarditis include urethral catheterization, colonoscopy, barium enemas, and surgical procedures.Late prosthetic endocarditis is not in any way related to the sterilization or packaging process of the device.A definitive root cause could not be determined; however, it is likely that patient related factors contributed to the event.Edwards lifesciences will continue to monitor all reported events.No further actions are required at this time.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EDWARDS INSPIRIS RESILIA AORTIC VALVE
Type of Device
TISSUE, HEART-VALVE
Manufacturer (Section D)
EDWARDS LIFESCIENCES
1 edwards way
irvine CA 92614
MDR Report Key8812607
MDR Text Key151758494
Report Number2015691-2019-02695
Device Sequence Number1
Product Code LWR
Combination Product (y/n)N
PMA/PMN Number
P150048
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,other
Type of Report Initial,Followup,Followup
Report Date 07/01/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/22/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date12/11/2020
Device Model Number11500A
Was Device Available for Evaluation? No
Date Manufacturer Received11/19/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age75 YR
-
-